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Abstract 
 Neurdegenerative diseases are characterized by the progressive decline of neuronal 
functions. Oxidative stress is considered the principal initiator of this problem, and 
contributes to the appearance of neurodegenerative diseases. In this study it was 
investigated the potential source of biocompounds with neuroprotective features of 
halophytes species. An initial screening of methanol extract of 26 species was made, using 
the 1,1-diphenyl-2picrylhydrazyl (DPPH) radical scavenging assay. The species 
Carpobrotus edulis was selected for the next assays, and used to prepare hexane, 
dichloromethane, chloroform, ethyl acetate and methanol extracts. The antioxidant activity 
was evaluated through different and complementary methods, namely the DPPH radical 
scavenging activity, iron and copper chelating activity, iron reducing power and nitric oxide 
(NO) scavenging activity, and for the phytochemical analysis, including total flavonoid 
content (TFC), total condensed tannin content (TCTC) and total phenolic content (TPC). 
These extracts were also tested for inhibition against enzymes related to neurodegenerative 
disorders, namely acetylcholinesterase (AChE), butirylcholinesterase (BChE) and 
tyrosinase (TYRO). 
The in vitro anti-inflammatory activity of the extracts was determined through the 
evaluation of the inhibition of NO production in lipopolysaccharide (LPS)-stimulated N9 
microglial cells. The neuroprotective activity was tested through the H2O2- induced injury 
in SH-SY5Y cell line, and the cellular viability measured by the MTT method. The 
methanol extract had the highest activity on the DPPH assay, and also the highest copper 
chelating activity and NO-scavenging activity. The hexane extract had the highest iron 
chelating activity, while the ethyl acetate extract had the highest iron reducing power 
activity. The methanol extract had the highest levels of total flavonoid content (TFC) and 
total phenolic content (TPC), while the dichloromethane extract had the highest total 
condensed tannin content (TCTC). All the extracts tested had a protective effect against 
H2O2- induced injury in SH-SY5Y cells, especially the methanol extract, which also had the 
highest anti-inflammatory activity in N9 microglial cells.   
 
Keywords: Halophytes, C. edulis, plant extracts, antioxidant activity, anti-inflammatory 
activity, enzyme inhibition, nitric oxide, phenolic compounds.
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Resumo 
 
 As doenças neurodegenerativas são caracterizadas pela progressiva degeneração do 
sistema nervoso. A perda contínua e específica de células neuronais pode conduzir a uma 
situação de doenças, como a doença de Alzheimer (DA) ou a doença de Parkinson (DP). O 
stress oxidativo é considerado uma das maiores e mais frequentes causas ou processo 
iniciador deste tipo de doenças. O envelhecimento conduz a um variado número de 
problemas para a saúde, incluindo o aumento de espécies reativas de oxigénio (ERO) que 
podem provocar danos celulares. A DA, a principal causa de demência na população, é 
caracterizada por distúrbios de comportamento, perda de memória e a diminuição da 
atividade cognitiva. Na DP os movimentos involuntários, associados a tremores, perda de 
força muscular e rigidez muscular são sintomas característicos desta doença. Em ambos os 
casos, a acumulação de neurotoxinas, de algumas proteínas e ERO conduzem a estados de 
inflamação crónica, perda de capacidade sináptica, levando assim à morte neuronal e ao 
agravamento dos sintomas. Diversos estudos têm provado a eficácia de compostos 
antioxidantes na redução da formação de ERO e de fortalecimento dos mecanismos de 
defesa dos organismos. Torna-se assim fundamental a pesquisa de produtos naturais que 
possuam propriedades antioxidantes e anti-inflamatórias. As plantas, devido às condições 
em que habitam, principalmente as halófitas, desenvolveram sistemas antioxidantes 
eficientes para proteção dos seus sistemas. As halófitas são capazes de sobreviver a 
ambientes com elevado teor de salinidade. Deste modo, podem desenvolver stress 
oxidativo, que é regulado por diversos mecanismos que facilitam a retenção e aquisição de 
água, proteção de cloroplastos, e manutenção da homeostase iónica. Essencialmente, estas 
ações compreendem a síntese de osmólitos (pequenos glícidos, polióis, aminoácidos e 
metilaminas), proteínas específicas (ex. enzimas antioxidantes, proteínas transportadoras de 
iões) e moléculas antioxidantes (ex. compostos fenólicos, carotenóides e vitaminas). Isto 
pode explicar a utilização de algumas espécies de halófitas em países orientais, na medicina 
tradicional e na alimentação. Para, além disso, sabe-se que as moléculas presentes em 
plantas, vulgarmente designadas por fitoquímicos, possuem propriedades antioxidantes e 
parecem ter uma atividade anti-inflamatória, eventualmente prevenindo o desenvolvimento 
destas doenças, através da inativação de algumas enzimas, prevenindo o stress oxidativo ou 
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ainda evitando a inflamação neuronal. O uso de compostos provenientes de halófitas para a 
prevenção de doenças neurodegenerativas ainda está pouco estudado. Neste estudo fez-se 
um screening inicial com 26 espécies de halófitas, fazendo um estudo da atividade 
antioxidante através do radical 1,1-difenil-2picrylhydrazyl (DPPH). A espécie Carpobrotus 
edulis foi selecionada para os seguintes ensaios. Foi efetuada uma extração sequencial com 
os solventes n-hexano, diclorometano, clorofórmio, acetato de etilo e metanol. Assim este 
estudo teve como objetivo estudar a atividade antioxidante, anti-inflamatória e 
neuroprotectora de extratos desta espécie. Através dos métodos de redução de radicais 
livres DPPH, da atividade quelante do cobre e do ferro, da atividade redutora do ferro e 
potencial de eliminação do óxido nitrico (NO) foi medida a capacidade antioxidante destes 
extratos. Os teores totais de compostos fenólicos, flavonóides e taninos foram igualmente 
determinados. Foi também testada a capacidade inibitória destes extratos contra algumas 
enzimas específicas, como a acetilcolinesterase (AChE), a butirilcolinesterase (BChE) e a 
tirosinase. Foram determinadas ainda a atividade anti-inflamatória e neuroprotectora em 
células de neuroblastoma (SH-SY5Y) e células de microglia (linha celular N9). Para o 
estudo da atividade anti-inflamatória foi utilizado o ensaio de Griess, que é um método 
simples e rápido para avaliar indiretamente a produção de óxido nitríco em meio aquoso, 
através da medição de nitritos, que é um produto final estável do óxido nitríco, na presença 
de oxigénio. Este método permite determinar o potencial inibitório dos extratos sobre a 
produção de óxido nitríco, na linha celular de células da microglia N9 estimulada com 
lipopolissacarídeo (LPS). A atividade neuroprotectora foi avaliada através do método de 
MTT, na linha celular SH-SY5Y estimuladas com peróxido de hidrogénio (H2O2), 
previamente tratadas com os extratos, procedendo-se posteriormente à medição da 
viabilidade celular. Todos os extratos mostraram possuir atividade antioxidante contra o 
radical DPPH, principalmente o extrato metanólico com uma atividade anti radical de 
96.1%, para a concentração de 1 mg/mL. O extrato metanólico permitiu obter ainda a maior 
atividade quelante do cobre (48.27% a 10 mg/mL), e de no radical NO (41.4% a 10 
mg/mL), enquanto na atividade quelante do ferro o extrato de hexano foi o mais ativo 
(81.32% a 10 mg/mL). A atividade redutora do ferro mais elevada foi obtida com o extrato 
de acetato de etilo (76.63% a 10 mg/mL). O extrato de metanol apresentou a maior 
concentração de flavonóides e fenólicos totais, enquanto o extrato de diclorometano 
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apresentou o teor mais elevado de taninos totais. A maior capacidade inibitória da AChE foi 
obtida com a aplicação do extrato de metanol (43.2% a 10 mg/mL), enquanto o de acetato 
de etilo foi o mais eficaz a inibir a BChE (60.4% a 1 mg/mL). Os extratos não apresentaram 
citotoxicidade nas linhas celulares utilizadas nos ensaios de neuroprotecção. Os extratos 
apresentaram capacidade para proteger a linha celular SH-SY5Y contra o stress oxidativo 
induzido pela aplicação de água oxigenada, traduzido numa redução da viabilidade para 
cerca de 50%, e o melhor resultado foi obtido com o extrato de metanol (143.5% de 
viabilidade celular a 50 μg/mL). A aplicação do extrato de metanol permitiu ainda uma 
redução significativa da produção de NO por células de microglia. Em conclusão, a espécie 
halófita C. edulis mostrou ser uma potencial fonte de compostos interessantes para o 
possível tratamento ou prevenção das doenças neurodegenerativas, em particular o extrato 
metanólico uma vez que foi o que permitiu obter melhores resultados. 
 
Palavras-chave: Carpobrotus edulis, halófitas, Alzheimer, Parkinson, atividade 
antioxidante, compostos fenólicos, inibição enzimática, atividade anti-inflamatória, 
atividade neuroprotectora, 
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1. Introduction  
 
1.1 Bioactive compounds 
 Bioactive compounds (BioA) can be characterized as crucial and non-crucial 
constituents that occur in small amounts in plant and animal products, and can influence 
cellular and physiological activities, contributing to a better health when included in the 
diet (Kris-Etherton et al., 2002, 2004; Biesalski et al., 2009). Some examples of BioA are 
flavonoids, isoflavones, phytoestrogens and monotrepenes, which can be found in many 
vegetables (Kris-Etherthon et al., 2002).  These compounds display several biological 
activities, namely antioxidant, anti-inflammatory and anti-tumoral (Kris-Etherton et al., 
2004; Ye et al., 2013). Apart from this activities, the definition of BioA implies that it 
displays comproved health benefits (Kris-Etherton et al., 2004; Biesalski et al., 2009), and 
can been taken through the diet or by medication.  
 Higher variety in fruit and vegetable intake has been associated with a lower risk of 
several chronic diseases and have been widely used to prevent and treat some disorders 
(Koppula et al., 2012; Ye et al., 2013). BioA have become popular due to have none or 
limited side effects, in contrast with synthetic drugs (Koppula et al., 2012). It is increased 
the search for BioA with a view to discover new antioxidant potential therapeutic 
compounds to attenuate or treat neurodegenerative diseases (Koppula et al., 2012).  
 
1.2. Neurodegenerative diseases 
 Neurodegenerative diseases (ND) are often hereditary and sporadic conditions 
which are characterized by progressive nervous system dysfunction, induced by deposits of 
abnormal proteins and other factors, which leads to a neuronal degeneration in particular 
areas of the brain (Ross et al., 2004). Alzheimer's disease (AD) and Parkinson's disease 
(PD) are examples of ND, and are characterized by the continued loss of specific neuronal 
cells in association with protein aggregation (Barnham et al., 2004; Ross et al., 2004). The 
oxidative stress is closely linked to these diseases, and is probably the responsible for the 
dysfunction of intracellular components, like proteins or neuronal cell death, which 
contributes to the development of these diseases (Barnham et al., 2004).  
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 The increasing age in population is deeply linked to the increase in the prevalence 
of several forms of ND (Forman et al., 2004). It is expected that by 2025, 75% of the 
world's population over 60 years of age living in developing countries will suffer of ND 
(Forman et al., 2004). The search for effective treatments or preventive interventions for 
ND is extremely important because in the near future the emotional, societal and financial 
burden of these aging-related disorders will be very high (Forman et al., 2004).  
 
1.2.1 Alzheimer’s disease 
 Alzheimer's disease (AD) is one of the main causes of dementia in aged population, 
affecting more than 35 million people worldwide (Prince et al., 2012). It was first identified 
in 1907 by Alois Alzheimer, in a 51-year-old woman, which exhibited personality changes, 
progressively worsening memory loss, time disorientation and language disturbances, 
despite the relatively normal neurological function (Nixon 2002; Forman et al., 2004). 
After autopsy, her brain revealed evidences of cerebral atrophy (Nixon 2002). There are 
many factors that contribute to AD, such as hypertension, oxidative stress, inflammation 
and hypercholesterolemia (Gamba et al., 2011). There are two forms of AD, the sporadic 
form, which affects 90% of the patients, and the familiar predisposition, that includes the 
remaining 10% (Nixon 2002). However, the two forms of the disease show the same 
neuropathology features (Nixon 2002). AD is normally recognized by characteristic 
symptoms namely behaviour disturbances, memory loss and decreasing of cognitive 
activity (Chitranshi et al., 2012), induced by the decrease of the forebrain cholinergic 
neurons, the most affected in this disease (García-Ayllón et al., 2011). With the advances of 
neuroimaging techniques, it is now possible to detect and measure the metabolism, atrophy 
and inflammation in brain, and the presence of plaques and neurofibrillary tangles (NFTs), 
as well the brain activity (Perrin et al., 2009). The research and development of biomarkers 
in AD is crucial to measure the structural and functional changes in the brain (Perrin et al., 
2009). Biomarkers like brain volume, atrophy, level  of glucose metabolism in the brain, 
regional activity changes, amyloid-plaque and NFTs formation, inflammation and oxidative 
stress are crucial on the preclinical phase of AD to make a diagnosis and prognosis, even 
before irreversible neurological damage occurs (Perrin et al., 2009; Alzheimer’s & 
Dementia, 2011). 
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 In Europe there are 7.3 million people with AD (Alzheimer-europe.org, 2014). In 
Portugal it is estimated that there are more than 180 000 cases, and due to the increase of 
elderly population it is estimated that the number of AD cases will increase (Alzheimer-
europe.org, 2014). Every year, 1.4 million Europeans develop dementia meaning that every 
24 seconds a new case is diagnosed. It is expected that by 2050 the number of the cases 
increases to 16.2 million (Forman et al., 2004; Alzheimer-europe.org, 2014). 
 
1.2.1.1. Neuropathology of AD 
 AD is characterized by extracellular deposits of amyloid-β peptide (Aβ), which 
form senile plaques and formation of intracellular neurofibrillary tangles (NFTs) composed 
of paired helical filaments (PHFs) of hyperphosphorylated protein tau (Resende et al., 
2008; Fig. 1.1). There are several studies showing that the accumulation of amyloid plaques 
and NFTs plays an important role in neurodegeneration during and before the clinical phase 
of the disease (Nixon 2002).  These structures are present in brain areas such as those 
involved in learning and memory, like the cortex and hippocampus (Nixon 2002; Resende 
et al., 2008). Such areas typically exhibit synaptic and neuronal loss, with cholinergic and 
glutamatergic neurons being the most affected (Resende et al., 2008). AD is also 
accompanied by inflammation, and neuronal, axonal and synaptic loss dysfunction (Perrin 
et al., 2009). These features are also found in cognitively normal elderly individuals and 
need to reach a certain threshold to be noticed by clinical symptoms (Perrin et al., 2009). 
 
 
 
 
 
 
 
 
 
Figure 1.1: Comparison of a healthy brain and a brain affected by AD, showing senile plaques and 
NFTs tangles leading to cortex atrophy. (Source http://img.docstoccdn.com/thumb/orig/90531693.png). 
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 AD has 4 clinical stages, described as “very mild/mild cognitive impairment” 
(MCI), “mild”, “moderate” and “severe” (Fig. 1.2). In the beginning of the “very mild” 
stage, the disease is correlated not with plaques or NFTs, but with synaptic and neuronal 
loss, supporting the idea that plaques and NFTs need to accumulate 10 to 15 years before 
cognitive decline is noticeable (Perrin et al., 2009).  
 
 
 
 
 
 
 
 
 
Figure 1.2: Progressive clinical stages of AD, “very mild/mild cognitive impairment” 
(MCI), “mild”, “moderate” and “severe”, correspond to clinical dementia rating (CDR) 
scores of 0.5, 1, 2 and 3, respectively. These stages are associated with abundant amyloid 
plaques (red line), the gradual accumulation of NFTs (blue line) and synaptic and neuronal 
loss in certain brain regions (green line). (Source: Perrin et al., 2009). 
 
1.2.1.2 β-amyloid plaques and neurofibrillary tangles 
 As stated before, the most common hallmarks of AD is the formation of senile 
plaques and NFTs (Perrin et al., 2009) (Fig. 1.1).  
 Senile plaques are composed by extracellular aggregates of Aβ. This peptide is 
formed from a larger amyloid precursor protein (APP), a transmembrane protein, which, in 
normal cases, is cleaved first by α-secretase and then by γ-secretase (Goedert et al., 2006; 
LaFerla et al., 2007; Karran et al., 2011). In AD cases the first cleavage was made by β-
secretase, which creates a shorter fragment known as β-amyloid (or Aβ) (LaFerla et al., 
2007). When fragments of Aβ aggregate they became toxic, interfering with the normal 
neuronal function (Butterfield et al., 2001; Perrin et al., 2009). With time these aggregates 
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increase in size and become soluble, originating the senile plaques and thus contributing to 
cell death (Butterfield et al., 2001; Perrin et al., 2009; Alzheimer’s & Dementia, 2011). The 
deposition of Aβ plaques is responsible for a chronic inflammatory response involving the 
activation of microglial cells (Nixon 2002; Dumont and Beal, 2011). Those reactions 
explains the presence of additional cell types in senile plaques, namely microglia and 
reactive astrocytes (Butterfield et al., 2001; Nixon 2002). Some of them accelerates the 
fibrillation of Aβ with the consequent formation of toxic products, which leads to a local 
development of dystrophic neurites (Butterfield et al., 2001; Nixon 2002). The primary 
damage to neurites initiates local Aβ overproduction, neurite degeneration-regeneration 
responses, and secondary inflammatory reactions involved in the removal of cellular debris 
(Nixon 2002). All these events cause more damage to the neurons through the formation of 
more toxic products and Aβ (Nixon 2002). 
 
1.2.1.3. Cholinesterases 
 Neurochemical studies show that the brain of AD patients has a disturbance of 
acethylcholine (ACh) metabolism, which led to the formulation of the “cholinergic 
hypothesis” (Carvajal and Inestrosa, 2011). This hypothesis postulates that the 
accumulation of Aβ and tau protein is connected to the loss of cholinergic neurons 
(Carvajal and Inestrosa, 2011).  
 Acetylcholinesterase (AChE) is a selective enzyme responsible for the hydrolysis of 
the cholinergic neurotransmitter ACh (Fig. 1.3; Ciro et al., 2012; Wang et al., 2012). AChE 
is present in all cholinergic structures, as well as in a subpopulation of non-cholinergic 
neurons and in glial cells (Ciro et al., 2012; Wang et al., 2012). Butyrylcholinesterase 
(BChE) also hydrolyses ACh and is present in a subpopulation of cortical and subcortical 
neurons and in glial cells (Ciro et al., 2012; Wang et al., 2012). It was demonstrated that 
intense cholinesterase (ChE) activity occurs in senile plaques and neurofibrillar tangles, 
which influences the aggregation of Aβ (Ciro et al., 2012). AChE inhibitors have been 
shown to interfere with the production of Aβ, by decreasing the levels of APP, thus 
reducing the toxicity effects associated with Aβ production and aggregation (Ciro et al., 
2012). Moreover, it is known that the expression of BChE increases as plaques go through 
the process of maturation, from the diffuse type to the pathologic compact variety (Ciro et 
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al., 2012). Thus, it is suggested that the influence of BChE in the pathology of plaques is 
greater than that of AChE, being essential in AD plaque maturation (Wang et al., 2012; Ciro 
et al., 2012). BChE shows to be a great contributor to the loss of ACh in AD brain, and is 
inhibition can lower the levels of Aβ peptide (Wang et al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic representation of synthesis of ACh. 1 - Acetylcholine is made from 
choline and acetyl CoA being afterwards incorporated and stored in presynaptic vesicles. 
Presynaptic vesicles then move or are emptied into the synaptic cleft, and the diffusion of 
ACh across the synaptic cleft to the postsynaptic ACh receptors occurs through binding of 
ACh to postsynaptic ACh receptor. 2 - After signalling, acethylcholine is released from 
receptors and broken down by acethylcholinesterase to be recycled in a continuous process. 
3 – Choline is reuptaked into the presynaptic neuron. (Source: http://peaknootropics.com/wp-
content/uploads/2013/08/acetylcholine-metabolism.png). 
 
1.2.2. Parkinson's disease 
 Parkinson's disease (PD) is a neurodegenerative pathology which affects 2-3% of 
the population above the age of 65 (Fasano et al., 2006) and 5% above 85 years, and is the 
second most common ND, after AD (Hasegawa et al., 2008; Bartels et al., 2009; Shulman 
et al., 2011). In Portugal there are between 13000 and 15000 people affected with this 
disease (Associação Protuguesa de Doentes de Parkinson, 2012). 
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 PD was initially reported by James Parkinson in 1817, and was based on six cases 
with a disease called then “Shaking Palsy”, which symptoms were involuntary tremulous 
motion, reduced muscular power, higher propensity to bend the trunk forward, and to pass 
from walking to a running pace, but where the cognitive abilities have not been injured 
(Zhang et al., 2000; Bartels et al., 2009). The neuropathological hallmark of PD, the Lewy 
body (LB), was described around 1912 by Friederichy Lewy (Forman et al., 2004, Bartels 
et al., 2009; Shulman et al., 2011). Around 1919, Konstantin Tretiakoff associated the loss 
of pigmented cells in the substantia nigra pars compacta (SNpc; the deep portion of 
substantia nigra) with the PD progression (Bartels et al., 2009). In the 1950’s Arvid 
Carlsson found a relationship between the decrease of dopamine and PD (Bartels et al., 
2009). 
 There are two forms of PD: a sporadic form, which affects 95% of all patients, and 
familial form accounting for about 5% of all cases (Hald and Lotharius, 2005). The familial 
form is associated with mutations in at least five genes, such as SNCA, PARK, PINK1, 
DJ1, UCHL1 and LRRK2 (Fig. 1.4; Hald and Lotharius, 2005; Tan and Skipper, 2007). The 
SNCA and PARK1 genes are linked to α-synuclein protein, promoting abnormal protein 
aggregation like showed in Fig. 1.4 (Tan and Skipper, 2007). Mutations in PARK and 
UCH-L1 cause a damage in the ability of the cellular machinery to detect and eliminate 
misfolded proteins (Duaer and Przedbarski., 2003). DJ1 gene have a role in the oxidative 
stress response, either as a redox sensor protein or as an antioxidant (Tan and Skipper, 
2007).  
 
 
 
 
Figure 1.4: Scheme of potential interactions between the encoded proteins of the different 
PD genes 
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 The aetiology of the sporadic form is still unknown (Zhang et al., 2000; Asanuma et 
al., 2003; Hald and Lotharius, 2005). Currently the most widely accepted hypothesis says 
that PD is a result of both genetics and environmental factors, leading to the failure of 
mitochondria, development of oxidative stress and occurrence of dopaminergic cells death 
(Hasegawa et al., 2008; Bartels et al., 2009; Nakashima et al., 2012). PD manifests through 
bradykinesia (extreme slowness of movements and reflexes), rest tremor, muscular rigidity, 
gait abnormalities and postural instability and in some cases dementia (Zhang et al., 2000; 
Montiel, 2006; Mosley et al., 2006; Zecca et al., 2008; Hauser and Hastings, 2013).  
 
1.2.2.1. Neuropathology of PD  
 The cell body of dopaminergic neurons project from the SNpc, which is responsible 
for the body movements, to the caudate nucleus and striatum, where neurons release 
dopamine (Zhang et al., 2000; Dauer and Przedbarski, 2003; Fasano et al., 2006; Mosley et 
al., 2006; Hauser and Hastings, 2013). In dopaminergic neurons, which also contain 
neuromelanin that confers a characteristic pigmentation to the SNpc area, the production of 
dopamine is affected and decreased, leading to cell degeneration and death (Fasano et al., 
2006; Shulman et al., 2011; Hauser and Hastings, 2013). This fact is shown by the 
depigmentation of SNpc, as shown in Fig 1.5. (Duaer and Przedbarski, 2003). This 
dopaminergic cell loss in SNpc results in dysfunctional motor movements (Shulman et al., 
2011).  
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Figure 1.5: Neuropathology of PD. (A) Schematic representation of the normal 
dopaminergic neurons whose cell bodies are located in the SNpc (black arrows). These 
neurons project (thick solid red lines, the nigrostriatal pathway) to the basal ganglia and 
synapse in the striatum (i.e., putamen and caudate nucleus). (B) Schematic representation 
showing the degeneration of nigrostriatal pathway in Parkinson’s patients there is a marked 
loss of dopaminergic neurons that project to the putamen (dashed line) and a much more 
modest loss of those that project to the caudate (thin red solid line). (C) 
Immunohistochemical labeling of intraneuronal inclusions, termed Lewy bodies, in a SNC 
dopaminergic neuron showing the differences between a normal neuron and a neuron from 
a PD patient. (Source: Duaer and Przedbarski, 2003). 
  
 The LB is an intraneuronal proteinaceous cytoplasmic inclusions, mostly composed 
by α-synuclein, a small acidic presynaptic protein, which is involved in vesicular transport 
(Fig. 1.5C; Fasano et al., 2006; Shulman et al., 2011; Irwin et al., 2013). 
 Although the causes of PD are not yet fully understood, data obtained from several 
studies support the theory that mitochondrial dysfunction and oxidative stress are involved 
in the progression of the pathogenic disease, which is strongly linked to dopaminergic 
neuronal loss (Mosley et al., 2006; Hasegawa et al., 2010; Hauser and Hastings, 2013). 
Besides these two factors, others, such as inflammation, excitotoxic mechanisms and toxic 
actions of nitric oxide (NO) are involved in PD development (Jenner 2003, Hasegawa et 
al., 2010; Hauser and Hastings, 2013).  
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 The microglia cells are important in surveillance and host defence in brain, aiding in 
the identification and removal of cells who are programed to death (Jenner 2003; Liu et al., 
2003). These cells are particularly sensitive to changes in their environment and turn active 
in case of injury or infection (Liu et al., 2003; Hald and Lotharius 2005). Several soluble 
factors are secreted by activated microglia cells, some have neuroprotective function, but 
the majority are neurotoxic and have proinflammatory activity, such as NO, superoxide 
anion and fatty acid metabolites (Liu et al., 2003; Hald and Lotharius 2005). Some 
experiments established a relationship between neuronal degeneration in PD and massive 
activated microglia, suggesting that activated microglia have a toxic effect in neurons (Liu 
et al., 2003; Hald and Lotharius 2005). 
  
1.2.2.2. Tyrosinase 
  Tyrosinase, also known as polyphenol oxidase, is a copper-containing 
monooxygenase enzyme widely distributed in organisms (Nerya et al., 2003; Chang 2012). 
This enzyme catalyses the formation of melanin pigment from tyrosine, oxidation of 
several phenolic compounds, the synthesis of amino acid based antibiotics among others 
(Senol et al., 2010; Chang 2012). It is implicated in the hydroxylation of tyrosine to 
DOPAquinone (dihydroxyphenylalanine-quinone), and oxidation of DOPAquinone to 
DOPA (dihydroxyphenylalanine), through dopamine-quinone via contributing to 
neuromelanin (NM) formation (Fig. 1.6; Asanuma et al., 2003; Greggio et al., 2005; Chang 
2012).  
 Dopamine is a potent neuromodulator in the central nervous system (CNS) that can 
be found in neuronal tissues and body fluids, in the form of large organic cations 
(Maciejewska et al., 2011). In fact dopamine is linked to PD, but the symptoms are 
recognized in AD patients too, showing that disturbance of dopamine metabolism may be 
closely associated also with AD (Silva and Ming, 2007). Catecholamines, dopamine, 
epinephrine, norepinephrine and DOPA are catechol-containing neurotransmitters, which 
are involved in cognitive, behavioural, physical, physiological and psychological functions 
(Silva and Ming, 2007). The oxidation of these molecules can cause severe alterations in 
brain activity, leading to neuronal death. Metabolic malfunctions of neurotransmitters are 
known phenomena in the physiology of AD and PD and have also been suggested to be 
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related to the neuropathology of these diseases (Silva and Ming, 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Tyrosine metabolism. (Source: Fiore et al., 2004). 
 
 Tyrosine is converted into DOPA through tyrosine hydroxylase (TH), being then 
carboxylated to form dopamine (Fig. 1.6; Xu et al., 1998; Asanuma et al., 2003). 
Dopamine, in the presence of tyrosinase, covalently modifies TH, which becomes disabled 
(Greggio et al., 2005). Tyrosinase can oxidise the catechol ring of dopamine turning it into 
the high reactive species dopamine-quinone, as showed in Fig. 1.7, which is responsible for 
the toxicity of the neurotransmitter (Greggio et al., 2005). The oxidation of dopamine 
inactivates dopamine transporters, the glutamate transporter and the mitochondrial 
respiration (Xu et al., 1998; Greggio et al., 2005; Hwang 2013). Dopamine-quinones can 
react with cysteine residues in the cytosol of neurons, and form protein adducts, which lead 
to irreversible modification or inactivation of functional proteins (Greggio et al., 2005). 
These quinones can also react with α-synuclein, stabilizing this toxic fibril intermediate, a 
dominant cause in PD (Greggio et al., 2005).  
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 Tyrosinase activity may also result in an increase in toxic effects of hydrogen 
peroxide (H2O2), being the peroxide a hallmark of oxidative stress and also an inhibitor of 
dopamine transporter (Gregiio et al., 2005), increasing the oxidative stress in neurons.  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Potential pathway for the synthesis of dopamine quinone (DA-quinone) and 
consequent damages. The DA-quinone is highly reactive and can change DNA or enhanced 
the formation of reactive oxygen radicals (superoxide, hydroxyl and peroxide). (Source: 
Stokes et al., 1996). 
  
 Neuromelanin is a dark insoluble polymer produced from dopamine oxidation that 
provide the dark pigmentation to the substantia nigra (Hwang 2013). Tyrosinase can 
accelerate the induction of catecholamine quinone derivates, due to its oxidase activity 
leading to dopamine neurotoxicity and neurodegeneration (Khan et al., 2007). 
Extraneuronal neuromelanin deposition has been observed in the brains of PD patients 
(Hwang 2013). When this neuromelanin is added to microglia cultures levels of NO 
increase, causing a strong microglia activation and consequently loss of dopaminergic 
neurons (Hwang 2013).  
Introduction 
13 
 
 Since these discoveries, the research of tyrosinase inhibitors as a target for the 
treatment of PD has become increasingly important. The current treatment relies on the 
administration of L-dopa, to increase dopamine levels in the brain, though a long-therm 
therapy may cause adverse reactions (Asanuma et al., 2003).  
 
1.3. Oxidative stress, antioxidants and ND 
 Oxidative stress has been regarded as a crucial factor in neurodegeneration 
(Friedman et al., 2011). Reactive oxygen species (ROS) and reactive nitrogen species 
(RNS), include radical anion superoxide (O2
-•), hydroxyl radicals (•OH), hydrogen peroxide 
(H2O2), and nitric oxide radical (NO
•). ROS and RNS are normal by-products of cellular 
metabolism, but react strongly with multiple molecules, leading to neurodegeneration (Behl 
and Moosmann, 2002; Barnham et al, 2004; Friedman et al, 2011; Hwang 2013; Taylor et 
al, 2013). Through different pathways, such as direct interaction with redox-active metals 
and oxygen species via reactions, like Fenton and Haber-Weiss reaction, the radical •OH 
has produced being the most reactive one of all ROS (Taylor et al., 2013).  
 The brain is characterized by a high oxygen consumption rate and lipid content, and 
by a relative shortage of antioxidant enzymes, compared with other tissues, making the 
CNS especially vulnerable to oxidative stress (Markesbery, 1996; Friedman et al., 2011). 
The chemical origin of ROS is the reaction between molecular oxygen with redox-active 
metals iron (Fe3+) and copper (Cu2+) (Barnham et al., 2004). To sustain many functions, the 
brain needs an elevated concentration of metal iron, but has a low capacity to manage the 
oxidative stress and low regeneration ability (Barnham et al., 2004). 
 Due to high content of polyunsaturated fatty acids (PUFA), like arachidonic (AA), 
and docosohexanoic acid (DCH), brain are more sensitive to oxidation, being an important 
mechanism of neurodegeneration (Butterfield and Lauderback, 2002; Floyd and Hensley, 
2002). AA and DCH are sensitive to free radical attack and PUFA decreased with the 
increase of lipid peroxidation (Butterfield and Lauderback, 2002). Lipid peroxidation is a 
process where molecular oxygen is integrated into unsaturated lipids (LH) and form lipid 
hydroperoxides (LOOH), like showed in Fig. 1.8 (Minotti and Aust 1992).  
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Figure 1.8: Reactions involved in lipid peroxidation. (Source: Minotti and Aust 1992). 
  
 These reactions are promoted by an “initiator” (I˙), which surpass the dissociation 
energy of an allylic bond and this cause a hydrogen abstraction and formation of a lipid 
alkyl radical (L˙; Minotti and Aust 1992). This alkyl radical can add oxygen to form lipid 
peroxyl radicals (LOO˙) which can liberate LOOH via hydrogen abstraction from a 
neighbour alkyl radical (Minotti and Aust 1992). It is necessary external oxidants, like •OH, 
to initiate lipid peroxidation, but once started the reaction this will propagate and form new 
LOOH (Minotti and Aust 1992; Valko et al., 2006). Transition metals, like Fe2+, increase 
the propagation of lipid peroxidation reaction (Minotti and Aust 1992; Valko et al., 2006). 
Fe2+ enters into Fenton and Haber-Weiss reaction, producing •OH. The increasing formation 
of •OH enhances the lipid peroxidation (Fig. 1.8 and 1.9; Minotti and Aust 1992; Behl and 
Moosmann, 2002; Barnham et al., 2004; Friedman et al., 2011; Hwang 2013; Taylor et al., 
2013).  
 
 
 
 
 
 
 
 
Figure 1.9: Schematic representation of hydroxyl radical production. In the Fenton reaction the 
Fe2+ reacts with H2O2 generating a very reactive and damage OH•. Ferric iron (Fe3+) react with O2-• 
through the Haber-Weiss reaction, leading to the regeneration of Fe2+. The production of highly 
reactive OH• promote the oxidative stress, lipid peroxidation, mitochondrial dysfunction, increases 
in intracellular calcium concentration, and lastly neuronal cell death. (Source: 
http://www.hindawi.com/journals/msi/2011/606807.fig.002.jpg). 
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 It is known that mitochondria, redox-active metals and inflammation (via activated 
microglia) are potential causes of oxidative stress in the brain (Fig. 1.10 and Fig. 1.11; 
Dumont and Beal, 2011). Oxidative stress is therefore considered one of the main causes 
for the development of different ND, including AD and PD (Halliwell 2001; Behl and 
Moosmann, 2002; Barnham et al., 2004). 
 
 In a brain of an AD patient, the content of Fe2+ and Cu2+ is increased, and can result 
in the production of free radicals (Jomova et al., 2010). Aβ plaques have been describe as 
metallic sinks because of the high concentrations of Cu, Fe and zinc (Zn) that have been 
found in this deposits (Barnham et al., 2004). In vitro studies evidenced that Cu2+ and Fe3+ 
induced peptide aggregation (Barnham et al., 2004). The homeostasis of Cu, Fe and Zn and 
their respective proteins, are severely modified in the AD brain (Barnham et al., 2004). 
Cu2+ and Fe3+ bound to Aβ may induce redox chemical reactions that reduce the oxidation 
state of both metals leading to the production of H2O2, and promoting the Fenton reaction. 
This, in turn, leads to the generation of extremely toxic OH• radicals inducing an 
inflammatory response by microglial cells (Barnham et al., 2004; Silva and Ming, 2007; 
Jomova et al., 2010). Aβ cause lipid peroxidation in brain cell membranes, and leads to 4-
hydroxy-2-nonenal (HNE) and acrolein formation (Butterfield and Lauderback, 2002). 
These reactive alkenals can alter the conformation of membrane proteins and are toxic to 
neurons (Butterfield and Lauderback, 2002). Protein oxidation can lead to diminished 
specific protein function which can induce cell death (Butterfield and Lauderback, 2002). 
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Figure 1.10: Scheme of the generation and role of free radicals in AD. Several key players, 
such as metals and Aβ, can exacerbate free radical production. Once accumulated inside the 
cell, free radicals can cause lipid, protein, DNA, and RNA damage and exacerbate AD 
pathogenesis. (Source: Dumont and Beal, 2011). 
  
 Dopaminergic neurons are vulnerable to oxidative stress due to the elevated 
consumption of oxygen, low levels of antioxidant enzymes and the synthesis and storage of 
dopamine (Taylor et al., 2013; Hwang 2013). The neurotransmitter dopamine is stable 
when inside synaptic vesicles, however outside the vesicles, as in a damaged neuron, 
dopamine is metabolised or auto-oxidised by in an oxygen rich environment producing 
ROS (Taylor et al., 2013; Hwang 2013). The oxidation of dopamine generates H2O2, 
reactive quinones and O2
-•, leading to a highly oxidative stress conditions (Taylor et al., 
2013). Neuromelanin, present in dopaminergic neurons, is a potent activator of microglia 
when released from dying cells, thereby increasing the sensitivity of this neurons to 
oxidative stress-mediated cell death, and promoting neuroinflammation (Hwang 2013; 
Taylor et al., 2013).  
 High levels of iron can also be an important factor in the initiation and promotion of 
neuronal death, due to interaction with neuromelanin and dopamine (Barnham et al., 2004; 
Taylor et al., 2013; Hwang 2013). Since the SNpc has increased levels of microglia cells, 
the activation of this cells caused by injuries, is more pronounced in PD (Taylor et al., 
2013). Such proneness to pro-inflammatory conditions has been related to elevated 
oxidative stress produced through the Fenton reaction (Fig. 1.8) (Hwang 2013; Taylor et al., 
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2013). Dopamine-quinone has the ability to directly modify some proteins, such as α-
synuclein, whose dysfunction and accumulation has been linked to PD, being another cause 
of oxidative stress (Hwang 2013). α-synuclein is a synaptic vesicle protein involved in 
neurotransmitter release, vesicle turnover, endoplasmic reticulum trafficking and synaptic 
plasticity, as shown in Fig. 1.11 (Taylor et al., 2013). The covalently modification of α-
synuclein, by dopamine-quinone, leads to conversion into a cytotoxic protofibril form 
(Hwang 2013). The mutation of the α-synuclein gene can increase its expression leading to 
formation of oligomers and finally insoluble polymers or fibrils (Barnham et al., 2004; 
Taylor et al., 2013). Both forms have been proved to be neurotoxic by inhibiting the 
complex I activity of mitochondria thus inducing leakage of dopamine into the cytosol, 
which in turn promotes dopamine quinone production and consequently increased ROS 
production and oxidative stress (Fig. 1.11; Jomova et al., 2010; Choi et al., 2012; Hwang 
2013; Taylor et al., 2013). Damages caused to the mitochondrial complex I in the electron 
transport chain leads to a leak of electrons, increasing ROS generation (Hwang 2013).  
   
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Oxidative stress in PD. The rule of DA and α-synuclein in oxidative stress 
process. The formation of NM leads to oxidative stress. (Source: Barnham et al., 2004). 
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 Oxidative stress occurs when there is an imbalance between ROS production and 
antioxidant defences leading to oxidation of biomolecules and severe cellular damage (Fig. 
1.12; Markesbery, 1996; Halliwell 2001; Orhan, et al 2007; Hauser and Hastings, 2013; 
Hwang 2013), namely DNA modification, enzymes inactivation, and structural proteins 
destruction (Behl and Moosmann, 2002; Barnham et al., 2004). Oxidative stress is present 
in most diseases and contributes to tissue injury. In order to cope with the overproduction of 
ROS, cells are endowed with several defence systems, being the antioxidants among the 
most important (Khan 2002; Hwang 2013). Antioxidants are compounds, synthetic or 
natural, that inhibit or delay the oxidation process by blocking the initiation or propagation 
of oxidizing chain reactions (Velioglu et al., 1998; Moreno et al., 2006). Natural 
antioxidants can be phenolic compounds, such as tocopherols, flavonoids and phenolic 
acids, nitrogen compounds, like alkaloids, chlorophyll derivates, amino acids and amines, 
and carotenoids as well as ascorbic acid (vitamin C) (Velioglu et al., 1998). Phenolic 
compounds are secondary metabolites present in a large abundance in plant tissues 
(Blokhina et al., 2003). Their antioxidants properties arise from their high reactivity as 
hydrogen or electron donors, from the ability of the polyphenol-derived radical to stabilize 
the unpaired electron, and from their ability to chelate transition metals ions, stopping the 
Fenton’s reaction (Blokhina et al., 2003). The ability of flavonoids to alter peroxidation 
kinetics by modification of the lipid packing order and to decrease fluidity of the 
membrane, is another mechanism who confers antioxidant properties to these compounds 
(Blokhina et al., 2003). Synthetic antioxidants like butylated hydroxyanisole (BHA) and 
butylated hydroxytoluene (BHT) have been used, but it is known now their carcinogenic 
potential, making the research for natural antioxidant drugs extremely important (Velioglu 
et al., 1998; Custódio et al., 2011).  
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 Moreover the antioxidants can be defined as enzymatic or non-enzymatic (Khan 
2002; Hwang 2013).  Non-enzymatic antioxidants, like tocopherol (vitamin E) and ascorbic 
acid (vitamin C), phenolic compounds and other small molecules, and enzymatic 
antioxidants, such as catalases and  peroxidases, which regulates the intracellular level of 
H2O2, superoxide dismutases (SOD), which catalyses the dismutation of superoxide to 
H2O2, and repair enzymes (Khan 2002; Blokhina et al., 2003). All this molecules work 
together in order to alleviate the ROS production by directly quenching oxygen radicals 
before they promote damages to cells (Khan 2002; Blokhina et al., 2003).  
Figure 1.12: Schematic representation of how oxidative damage is exerted on brain. The 
oxidant species noted are produced and interact with cellular targets producing unique 
oxidation products and they, in some cases in turn, exert oxidative stress upon the tissue 
also. (Source: Floyd and Hensley 2002). 
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1.4. Neuroinflammation: the role of microglia 
 Microglia cells are the resident phagocytes and innate immune cells of the brain, 
and play an important role in inflammatory responses being important in homoeostasis, as 
well as in various pathologies of the CNS (Liu et al 2012). Reactive microglia are 
hallmarks of AD, and these brain cells are likely to contribute to the mechanisms of 
neuronal damage and cognitive loss associated with that disease (Branden et al., 2012). The 
activation states in microglia are similar to the macrophages and exhibit a functional 
plasticity during activation states (Branden et al., 2012). In inactive or quiescent state, these 
cells have a surveillance function, while in an active state they have two functionally 
distinct states, M1 and M2 with different functions (Branden et al., 2012). Microbial 
compounds and pro-inflammatory cytokines induce the classical activation of macrophages, 
the M1 state in microglia cells (Branden et al., 2012. The M2 state, also known as 
alternative activation state (Liu et al 2012), is responsible for anti-inflammatory activity by 
blocking the release of pro-inflammatory cytokines, ingesting debris, promoting tissue 
repair and releasing neurotrophic factors (Branden et al., 2012). The microglia cells 
respond to exogenous and endogenous stimuli originating a cascade of inflammatory 
molecules (Liu et al 2012). They can be activated in response to lipopolysaccharide (LPS) 
stimulation, and in consequence of this activation, cells secrete ROS and pro-inflammatory 
cytokines, such as interleukin-1β (IL-1β), which cause neuronal injuries (Branden et al., 
2012). IL-1β is one of the molecules responsible for neuroinflammation, and has a direct 
effect on neurons causing glial cells and neurons to release multiple inflammatory 
mediators leading to self-amplifying neuroinflammation (Zhou Wu et al., 2013).  
 Microglial cells are activated when the protein β-amyloid form oligomers and 
amyloid deposits, and migrate towards plaques as they are formed (Fig. 1.13; Perrin et al., 
2009). The astrocytes become reactive, and numerous inflammatory mediators, signalling 
molecules, oxidative processes, complement cascades and modulators of protease activities 
are released (Perrin et al., 2009). Dendrites and axons become dystrophic, due to this 
transport process malfunctions, leading to altterations in brain metabolism (Perrin et al., 
2009). Apart from the formation of NFTs, neurons suffer many other changes: synapses are 
lost because they are dysfunctional, and neurons die (Perrin et al., 2009).  
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Figure 1.13: Schematic histological representation of biomarkers in relation to Alzheimer’s 
disease pathology. Produced by neurons, Aβ42 becomes deposited in plaques, which activate 
microglia. Microglia release cytokines (for example IL-1β and TNF-α). Microglia and 
neurons also produce complement factors that can be activated by amyloid-β aggregates, 
and cause synapse loss. Tau becomes hyperphosphorylated and aggregates into NFTs in 
neurons and dystrophic neurites around plaques; its mechanism of release from neurons is 
uncertain. (Source: Perrin et al., 2009).  
 
1.5. Actual treatments for AD and PD 
 Some studies show that AChE inhibitors have beneficial effects on cognitive, 
functional, and behavioural symptoms of AD (Scarpini et al., 2003). There are four 
cholinesterase inhibitors approved by the US Food and Drug Administration, the tacrine, 
donepezil, rivastigmine and galantamine (Scarpini et al., 2003). In Europe the availability 
differs from country to country, and only rivastigmine has been approved centrally by 
European Agency for the Evaluation of Medical Products (EMEA; Scarpini et al., 2003). 
Tacrine, the first approved drug for AD, is a potent non-selective inhibitor of both AChE 
and BChE (Franco et al., 2005). Although this hepatotoxicity and absence of selectivity 
have reduced is therapeutic use, the search of tacrine analogues is still of interest (Franco et 
al., 2005). Rivastigmine inhibits both AChE and BChE, while donepezil inhibits only 
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AChE (Bullock et al., 2005). These therapeutic drugs have common adverse events such as 
nausea, vomiting, diarrhoea, dizziness and weight loss (Hansen et al., 2008).  
 
 In PD the widely used and effective treatment is with L-DOPA and has been shown 
to benefit certain cognitive functions, although detrimental effects can also develop 
following L-DOPA therapy (Cools 2006). L-DOPA impairs some, but improves other 
complex cognitive abilities (Cools 2006). A long-term treatment with this medicament can 
lead to a disabling abnormal involuntary movements, also known as L-DOPA induced 
Dyskinesia (LID), characterized by uncontrolled and repetitive movement in the axis, arms, 
legs and oro-facial zone (Bravo et al., 2014). These facts are a serious limitation to the use 
of L-DOPA, and become important the search for new way of treatments and new 
therapeutic targets (Bravo et al., 2014).  
 Because of all these facts presented it becomes even more important the research for 
natural therapies and also new targets, with the prospect of being more efficient and with 
fewer side effects.  
 
1.6 Halophytes 
 Halophytes can live in extreme saline conditions and grow and reproduce in 
different saline biotypes, such as dunes, rocky coasts, saline depressions, saline inland 
deserts and in salt marches (Ksouri et al., 2011). In order to survive in these habitats, these 
plants have developed the ability to resist to toxic ROS, prooduced in response to 
unfavourable environment conditions: they are endowed with a powerful antioxidant 
system, including enzymes and secondary metabolites, which can delay the oxidation of 
molecules through the inhibition of the initiation and propagation of oxidative chain 
reaction (Ksouri et al., 2011). Due to its unique chemical content, halophytes are a 
promising source of bioactive compounds, such as vitamins, polyunsaturated fatty acids 
(PUFAS), and phenolic compounds (Ksouri et al., 2011). The importance of these 
compounds has been recognized in connection with health promotion, disease risk 
reduction and decrease in health care costs (Ksouri et al., 2011). 
 In the last years scientific research has focused in terrestrial and marine natural 
products with commercial and scientific interests, having found already several thousand 
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novel molecules with biological activities (Haefner 2003). Studies of bioactivities in 
halophytes from the Coast of Portugal are however limited, despite the great abundance of 
this plants in this particularly region (Haefner 2003; Custodio et al., 2012) 
 
1.6.1. Carpobrotus edulis 
 Carpobrotus edulis (Syn. Mesembryanthemum edule; sour fig, Aizoaceae, Fig. 
1.14), is a succulent perennial halophyte spread along the coastal areas of Europe, Africa, 
Australia and California. In the past it was introduced in Portugal to stabilized and fix 
coastal sand dunes (Conser and Connor 2009). Nowadays it is considered an invasive 
species which form impenetrable mats that occupy large areas, preventing the development 
of native vegetation due to the acidification of the soil that they induce (Conser and Connor 
2009). 
 Sour fig is used in traditional medicine in some areas of South Africa, to treat fungal 
and bacterial infections and some diseases like tuberculosis, throat infections, sinusitis, 
dysentery, diarrhoea, infantile eczema, mouth ulcers, toothache and oral and vaginal thrust 
(Martins et al 2011; Ksouri et al., 2011; Custodio et al., 2013). Compounds such as uvaol, 
β-amyrin, oleanolic acid, catechin, epicatechin and monogalactosyldiacylglycerol have 
been isolated from C. edulis, and their anticancer activity has been suggested (Martins et al 
2011; Custodio et al., 2013). Moreover phenolic compounds from C. edulis, show 
antioxidant activity, anti-atherosclerotic and anti-inflammatory properties, and protect 
against congestive heart failure. 
  
 
 
 
 
 
 
 
Figure 1.14. Carpobrotus edulis. (Source: http://www.onlyfoods.net/wpcontent/uploads/2012/09/ 
Carpobrotus-Edulis.jpg). 
Introduction 
24 
 
1.6. Aims of the thesis 
 There are several studies on the antioxidant, anti-inflammatory and cytotoxicity 
activities of different plant species. However, the reports on these bioactivities on 
halophytes are rare. Halophytes are choose to this work because they are potential source of 
bioactive compounds, whom normally exhibits interesting activities. In this context, the 
major goal of this work was to study the in vitro antioxidant, enzyme inhibition, like 
Acetylcholinesterase, Butirylcholinesterase and Tyrosinase, neuroprotective, anti-
inflammatory activities of different extracts of selected halophyte species common in the 
southern Portugal (Algarve).  
 These activities were selected in order to: 
- Evaluate the neuroprotective potential activity, through the determination of the 
antioxidant capacity of halophyte extracts;  
- Evaluate the anti-inflammatory activity through nitric oxide inhibitory effect of 
halophyte extracts; 
- Investigate the enzyme inhibitory activity of halophyte extracts.  
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2. Materials and Methods 
2.1 Plant material 
 In this work 26 halophyte species were used, namely, Halimione portulacoides, Beta 
maritima, Carpobrotus edulis, Cotula coronopifolia, Frankenia laevis, Hordeum marinum, 
Juncus acutus, Limonium algarvense, L. ferulaceum, Limoniastrum monopetalum, 
Mesembryanthemum crystallinum, Phragmites australis, Plantago coronopus, Polygonum 
maritimum, Polypogon maritimus, Salicornia ramosissima, Salsola vermiculata, 
Sarcocornia fruticosa subsp. alpini, S. fruticosa subsp. perennis, Scirpus maritimus, 
Spartina densiflora, S. maritima, Sporobolus sp., Suaeda vera, Tamarix africana and 
Lampranthus sp. Biomass was collected in Southern Portugal, namely in Ludo, Praia de 
Faro and Castro Marim, during the summer of 2010. The aerial parts of the above 
mentioned species were cleaned from extraneous matter, dried at 40°C for 2-3 days, 
powdered and stored at -20°C. 
 
2.2 Supplements, chemicals and culture media 
 Sodium nitrite, sodium acetate, 1,1-diphenyl-2picrylhydrazyl (DPPH), electric eel 
acethylcolinesterase (AChE) (type-VI-S, EC 3.1.1.7), horse serum butyrylcholinesterase 
(BChE) (EC 3.1.1.8), galanthamine, acetylthiocholine iodide and butyrylthiocholine 
chloride, 5,5-dithio-bis(2-nitrobenzoic) acid (DTNB), lipopolysaccharide (LPS) from 
Escherichia coli, 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT), 
tyrosinase (EC 1.14.1.8.1, 30 U, mushroom tyrosinase), N-(1-Naphthyl) ethylenediamine 
dihydrochloride (NED) were purchased from Sigma-Aldrich (Germany). Merck (Germany) 
supplied Folin-Ciocalteau (F-C) phenol reagent, phosphoric acid and ferrospectral. Lonza 
(Belgium) provided Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum 
(FBS), trypsin, L-glutamine and penicillin/streptomycin. Dimethylsulfoxide (DMSO), 
ethylenediamine tetraacetic acid (EDTA), copper (II) sulphate and additional reagents and 
solvents were obtained from VWR International (Belgium) 
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2.3. Preparation of the extracts 
 For the initial screening, dried biomass was powdered and a single overnight 
methanol (1:40 w/v) extraction was performed, at room temperature with stirring. The 
extracts were then filtered with filter paper (Whatman no. 4) and concentrated at 40-50ºC 
under reduced pressure, and dried under a gentle flow of nitrogen. Dried extracts were 
weighed, and dissolved in DMSO at a concentration of 10 mg/mL. 
 C. edulis was subjected to sequential extraction with different polarities solvents in 
order to obtain different compounds with different polarities in each extract. That way we 
have an arrangement of different compounds with different activities, and can choose the 
extract(s) who better fit in our study. Dried sample of C.edulis, were extracted in a Soxhlet 
apparatus for 2 hours with each solvent, in the order: n-hexane, dichloromethane, 
chloroform, ethyl acetate, and methanol. In each extraction 50 gr of sample and 250 mL of 
solvent were used. Extracts were filtered with filter paper (Whatman no. 4), and evaporated 
under reduced pressure. Dried extracts were weighed, dissolved in DMSO to a final 
concentration of 50 mg/mL and stored at 4ºC.  
 
2.4 Determination of antioxidant activity 
2.4.1. Radical scavenging activity (RSA) of DPPH 
The DPPH assay was performed according to the method of Brand-Williams et al. (1995), 
as described by Moreno et al. (2006). Samples (22 μL) were mixed with 200 μL of 
methanol DPPH solution (120 μM) in 96-wells microplates and incubated for 30 min. at 
room temperature (RT), in the dark. Hexane, dichloromethane, chloroform and ethyl acetate 
extracts were tested at the concentrations of 1, 5 and 10 mg/mL. Methanol extract was 
tested at 0.010, 0.100 and 1 mg/mL. A colour control was made to exclude any absorbance 
by the crude extract. This control was made by adding 22 μL of extract plus 200 μL of 
methanol solvent. The DPPH solution was used as a negative control, while butylated 
hydroxytoluene (BHT, E320) was used as positive control at the concentration of 1 mg/mL. 
The absorbance was measured at 517 nm using a Biotek Synergy 4 microplate reader and 
antioxidant activity (%) was calculated according to the following equations:  
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% inhibition = (Absorbance of negative control – Absorbance of test sample) x 100 / 
Absorbance negative control 
Where 
Absorbance of test sample = Absorbance of test solution – Absorbance of colour control 
 
2.4.2 Iron (ICA) chelating activity 
ICA was determined according to the method described by Megías et al. (2009). The 
samples (30 μL) were mixed in 96-well microplates with 250 μL of 100 mM Na acetate 
buffer (pH 4.9) and 30 μL of an aqueous FeCl2 solution (0.1 mg/mL, w/v). After 30 min., 
12.5 μL of 40 mM ferrozine aqueous solution were added. The change in colour was 
measured at 562 nm in a microplate reader (Biotek Synergy 4), and the results expressed as 
percentage inhibition, relatively to a negative control solution containing methanol or 
DMSO in place of the sample. Extracts were tested at the concentrations of 1, 5 and 10 
mg/mL. The synthetic metal chelator EDTA was used as a standard at 1 mg/mL.  
 
2.4.3 Copper (CCA) chelating activity 
CCA was evaluated using pyrocatechol violet (PV) according to Megías et al. (2009). 
Samples (30 μL) were mixed in 96-well microplates with 200 μL of 50 mM Na acetate 
buffer (pH 6.0), 6 μL of 4 mM PV dissolved in the buffer and 100 μL of CuSO4.5H2O (50 
μg/mL, w/v). The change in colour was measured at 632 nm, using a microplate reader 
(Biotek Synergy 4). Results were expressed as percentage of inhibition relatively to a 
negative control solution containing methanol or DMSO in place of the sample. Extracts 
were tested at the concentrations of 1, 5 and 10 mg/mL. The synthetic metal chelator EDTA 
was used as a standard at 1 mg/mL.  
 
2.4.4. Iron Reducing power 
Iron reducing power was determined according to the method described by Megías et al. 
(2009). The samples (50 μL) were mixed in 96-well microplates with 50 μL of distilled 
water and 50 μL of 1% potassium ferricyanide and incubated at 50ºC for 20 min. Then, 50 
μL of 10% trichloroacetic acid and 10 μL of 0.1% ferric chloride were added and incubated 
for 20 min. at 50ºC. Absorbances were read at 700 nm on a microplate reader (Biotek 
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Synergy 4). Samples were tested at 1, 5 and 10 mg/mL. BHT (butylated hydroxytoluene) 
was used as positive control at 1 mg/mL. Results were expressed relatively to the positive 
control. 
% Activity = (100 x absorbance of test sample) / Absorbance positive control 
Where 
Absorbance of test sample = Absorbance of test solution – Absorbance of colour control 
 
2.4.5. Nitric oxide (NO) - scavenging activity 
NO scavenging activity was measured according to Ebrahimzadeh et al. (2010), adapted to 
96 well plates. Briefly, 50 μL of the extracts were mixed with 50 μL of 10 mM sodium 
nitroprusside in phosphate buffer (PBS) in 96-well microplates, and incubated for 90 min at 
RT. Then, 50 µL of Griess reagent (1% of sulphanilamide and 0.1% of 
naphthylethylenediamine in 2.5% HPO3) were added and the change colour was recorded at 
546 nm using a microplate reader (Biotek Synergy 4). Ascorbic acid was used as positive 
control at 1 mg/mL. Results were expressed as percentage of activity, relatively to a 
negative control Containing DMSO in place of the sample. 
 
2.5. Phytochemical analysis 
2.5.1 Total flavonoid content (TFC) 
TFC was determined by the aluminium chloride (AlCl3) colorimetric method adapted to 96-
well microplates (Zou et al., 2012). Aliquots (30 µL) of the extracts at 1 mg/mL were 
mixed with 180 µL of distilled water, and 10 µL of 5% sodium nitrite (NaNO2). After 6 
min. of incubation, 20 µL of 10% of AlCl3 (in methanol) were added and the solution was 
further incubate for another 6 min. Then, 60 µL of 4% sodium hydroxide (NaOH) was 
added, the mixture further incubated for 15 min, and the absorbance measured at 510 nm in 
a microplate reader (Biotek Synergy 4). TFC was calculated based on a standard curve of 
rutin solutions and results expressed as milligram of rutin equivalents per gram of dried 
extract (mg RE/ g dry weight, DW). 
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2.5.2. Total condensed tannin content (TCTC) 
TCTC of the extracts was evaluated by the 4-dimethylaminocinnamaldehyde (DCAMA) 
colorimetric method adapted from the vanillin method to 96-well microplates (Zou et al., 
2012). 10 µL of each extract at 1 mg/mL were mixed with 200 µL of 1% of DCAMA (in 
methanol), and 100 µL of 37% HCl. After 15 min of incubation the absorbance was read at 
640 nm in a microplate reader (Biotek Synergy 4). TCTC was calculated based on a 
standard curve of catechin solutions and results expressed as milligrams of catechin 
equivalents per gram of dried extract (mg CE/ g, DW). 
 
2.5.3. Total phenolic content (TPC) 
TPC of the extracts was determined by the Folin-Ciocalteau (F-C) colorimetric assay 
according to Velioglu et al. (1998). The experiments were performed in 96-well plates: 5 
μL of each extract at 1 mg/mL were mixed with 100 μL of F-C (1:10, v/v in water). After 5 
min, 100 μL of sodium carbonate solution (75 g/L) were added, and the mixture incubated 
at RT for 90 min, in the dark. The absorbance of each sample was measured at 725 nm in a 
microplate reader (Biotek Synergy 4). Results were calculated based on a standard curve of 
gallic acid solutions and results expressed as milligrams of gallic acid equivalents per gram 
of dried extract (mg GAE/ g, DW). 
 
2.6. Enzyme inhibition assays 
2.6.1. Acetylcholinesterase (AChE) and butirylcholinesterase (BChE) inhibition 
The inhibitory activity of AChE and BChE was determined according to the methods 
described by Orhan et al. (2007). Briefly, 140 μL of 0.1 mM sodium phosphate buffer (pH 
8.0) were mixed with 20 μL of the extracts at 1, 5 and 10 mg/mL, and 20 μL of 
AChE/BChE (0.28 U/mL) in 96-well microplates. After a 15 min incubation period at 37ºC, 
10 μL of acetylthiocholine iodide (ATChI) or butyrylthiocholine chloride (BTChI), at 4 
mg/mL were added to start the hydrolysis reaction, catalysed by the enzymes. Then, 20 μL 
of 5,5-dithiobis-(2-nitrobenzoic) acid (DTNB) (1.2 mg/mL) were added to form the yellow 
5-thio-2-nitrobenzoate anion as a result of DTNB reaction with the thiocholines, produced 
as a result of AChE or BChE activity. This anion was detected at 412 nm, in a 96-well 
microplate reader (Biotek Synergy 4). Galanthamine, an anticholinesterase alkaloid-type 
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drug isolated from the bulbs of snowdrop (Galanthus sp.) was used as a positive control at 
1 mg/mL.  
 
2.6.2. Tyrosinase (TYRO) inhibition 
TYRO inhibition was determined according to the method described by Nerya et al. (2003) 
with some modifications. Samples were diluted in 50 mM potassium phosphate buffer 
solution (pH 6.5) to obtain concentrations of 1, 5 and 10 mg/mL. Extracts (70 μL) were 
mixed in 96-well microplates with 30 μL of tyrosinase (333 Units/mL in buffer), and 
incubated for 5 min at RT. Then, 10 μL of substrate (2 mM L-Tyrosine) were added, 
incubated at RT for 30 min, and the optical density read at 492 nm using a microplate 
reader (Biotek Synergy 4). Results were expressed as % of tyrosinase inhibition relatively 
to a negative control solution containing potassium phosphate buffer solution in place of 
the sample. The positive control used was arbutin at 1 mg/mL. 
 
2.7. Neuroprotective activity using cell-based method 
2.7.1. Protective effect against H2O2-induced injury in neuronal cells 
2.7.1.1. Cell culture and viability determination 
The human neuroblastoma cell line (SH-SY5Y cells) was maintained in Dulbecco’s 
modified eagle medium (DMEM) with 4500 mg/mL of glucose, 10% heat inactivated fetal 
bovine seurm (FBS), l-glutamine (2 mM), penicillin (50 U/mL) and streptomicin (50 
µg/mL), and maintained in an incubator at 37ºC, in a 5.1% CO2 humidified atmosphere. To 
evaluate the effect of the extracts on the viability of SH-SY5Y cells, they were seeded in 
96-well plates at a density of 2 × 104 cell/well and incubated for 24 h. Then, 100 µl of the 
extracts at 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL were added and plates further incubated 
for 24 h. Cell viability was determined by the MTT assay (Mosmann, 1983). Briefly, 2h 
prior to the end of the incubation period, 20 μL of MTT (5 mg/mL in PBS) were added to 
each well and incubated at 37ºC. Then, 150 μL of DMSO were added to each well in order 
to dissolve the formazan crystals produced and absorbance was measured at 590 nm 
(Biotek Synergy 4). Samples allowing cell viability higher than 80% were selected and 
used to assess their protective effect of the extracts against H2O2 induced oxidative stress 
on SH-SY5Y cells. 
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2.7.1.2. Protective effect against H2O2 induced oxidative stress on SH-SY5Y cells  
SH-SY5Y cells were seeded at a density of 2 × 104 cells/well in 96-well culture plates, left 
to adhere overnight, treated with non-toxic concentrations of the extracts in culture medium 
and incubated for 24 h. Then, H2O2 (1 mM) was added for 30 min. and cell viability was 
determined by the MTT assay (Mosmann, 1983) as described in section 2.7.1.1. A stock 
solution of H2O2 was prepared on phosphate-buffered saline (PBS, pH 7.4) and diluted with 
DMEM without FBS immediately before use. 
 
2.7.2. Anti-inflammatory activity on LPS-stimulated microglia cells  
2.7.2.1. Cell culture and viability determination 
The murine microglial cell line N9 was cultured in Dulbecco’s modified eagle medium 
(DMEM) in the same conditions described in section 2.7.1.1 for neuronal cells. To evaluate 
the effect of the extracts on the viability of N9 cells, extracts were applied at concentrations 
ranging from 3.125 to 100 μg/mL, incubated for 24 h, and cell viability was determined by 
the MTT assay (Mosmann, 1983). Samples allowing cell viability higher than 80% were 
selected to assess for anti-inflammatory activity, through inhibition of NO production by 
LPS-stimulated microglia cells. 
 
2.7.2.2. Quantification of nitric oxide (NO) production on LPS-stimulated microglia 
cells 
N9 cells were seeded at a density of 1 x 106 cells/well in 24-well plates and incubated for 
24h. Then, cells were treated with 200 μL of the extracts at various concentrations (3.125, 
6.25, 12.5, 25, 50 and 100 μg/mL), in serum- and phenol-free culture medium, for 24 h, 
with 200 μL of LPS (10 μg/mL). Control cells were treated with DMSO at the highest 
concentration used in test wells (0.5%, v/v) with and without LPS. The NO production in 
the cell culture medium was measured spectrophotometrically using the Griess reaction 
(Miranda et al., 2001). Stock Griess solution was prepared with equal amounts of a solution 
of 1% (w/v) sulphanilamide + 0.1% of N-(1-Naphthyl)-ethylenediamine dihydrochloride 
(NED) and 2.5% (v/v) phosphoric acid. After the incubation period with the plant extracts 
and/or LPS, 100 μL of the culture supernatants were mixed with the 100 μL of Griess 
reagent in 96-well microplates. After 20 min, of incubation at RT, in the dark, absorbance 
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was measured at 540 nm on a microplate reader (Biotek Synergy 4). Nitrite concentration 
was determined using a calibration curve prepared with several concentrations (1.7, 3.1, 
6.2, 12.5, 25, 50 and 100 μM) of sodium nitrite as standard. Results were expressed as μM 
of nitric oxide. 
 
2.8 Statistical analysis 
Results were expressed as mean ± standard error of the mean (SEM), and all experiments 
were conducted at least in triplicate. Analysis of variance (ANOVA) using the Duncan’s 
honest significant difference (HSD) test was used to assess differences between means. 
Samples were considered significantly different when P < 0.05. The SPSS statistical 
package for Windows (release 15.0, SPSS INC) was used. 
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3. Results 
 
3.1 Determination of antioxidant activity 
3.1.1 Radical scavenging activity (RSA) of DPPH•  
 In this work, methanolic extracts from twenty six halophytes species were screened 
for RSA on the DPPH radical. The extracts were tested at 1 mg/mL and results are 
summarized on Table 3.1. 
  
Table 3.1. RSA on DPPH free radical• (%) of methanolic extracts of 26 species of 
halophytes collected in the Southern Portugal, applied at the concentration of 1 mg/mL.  
Species DPPH 1mg/mL 
Halimione portulacoides 6.95 ± 1.46 
Beta maritima n.a 
Carpobrotus edulis 95.7 ± 0.2* 
Cotula coronopifolia 18.7 ± 0.3 
Frankenia laevis 95.2 ± 0.0* 
Hordeum marinum 20.9 ± 0.2 
Juncus acutus 29.8 ± 0.5 
Limonium algarvense 95.7 ± 0.3* 
Limonium ferulaceum 91.7 ± 0.3 
Limoniastrum monopetalum 63.5 ± 1.0 
Mesembryanthemum crystallinum 10.9 ± 0.4 
Phragmites australis 39.5 ± 0.9 
Plantago coronopus 31.2 ± 0.3 
Polygonum maritimum 95.4 ± 0.4* 
Polypogon maritimus 46.4 ± 1.0 
Salicornia ramosissima 19.9 ± 0.4 
Salsola vermiculata 40.1 ± 0.5 
Sarcocornia fruticosa subs. alpini 93.1 ± 0.1 
Sarcocornia fruticosa subs. perenis 18.3 ± 0.3 
Scirpus maritimus 75.8 ± 0.8 
Spartina densiflora 8.72 ± 0.64 
Spartina maritime 2.45 ± 0.48 
Sporobolus sp. 20.9 ± 0.5 
Suaeda vera 29.5 ± 0.3 
Tamarix africana 95.0 ± 0.1* 
Lampranthus sp. 69.8 ± 0.7 
BHTa 89.1 ± 0.1 
 
Each value corresponds to mean ± SEM (n = 12). ª Positive control; * significantly higher 
that the positive control (p < 0.05). n.a: no activity. 
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 Several species had high antioxidant activity, and the best results were obtained with 
C. edulis (95.7%), F. laevis (95.1%), L. algarvense (95.6%), P. maritimum (95.3%) and T. 
africana (95.0%), all significantly higher than the pure antioxidant compound BHT used at 
the same concentration as the samples. Based on these results we selected C. edulis for 
further work, having in mind not only its high RSA, but also the fact that it is an invasive 
species in several locations, including Portugal (Rodrigues et al, 2014). In fact, populations 
of C. edulis are often submitted to physical removal in order to reduce the area occupied by 
this species; a biotechnological use for the resulting biomass would provide a sustainable 
use of such an abundant resource (Rodrigues et al, 2014). 
Dried biomass of C. edulis was sequentially extracted in a Soxhlet apparatus using solvents 
of increasing polarities namely hexane, dichloromethane, chloroform, ethyl acetate and 
methanol. Those extracts where then tested for RSA activity using the DPPH assay at 
concentrations ranging from 0.010 mg/mL to 10 mg/mL (Fig. 3.1). 
Figure 3.1: RSA on the DPPH radical of the extracts of C. edulis and positive control 
(BHT). Solid bars and errors bars represent the average and standard error values, 
respectively (n = 12). Results are calculated in respect to the negative control. Significant 
differences between concentrations, between extracts and the positive control were 
determined by the Duncan HSD test (p < 0.05) and are indicated by different letters (a-n). 
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 All the extracts showed a dose-dependent RSA against DPPH• and the highest 
activity was observed with the methanol extract at the concentration of 1 mg/mL, with a 
RSA value of 96.1%, significantly higher than the one obtained with the positive control 
used, BHT (89.1%; p<0.05; Fig. 3.1). 
 
3.1.2 Iron (ICA) and copper (CCA) chelating activity 
 The extracts were tested for ICA and CCA at the concentrations of 1, 5 and 10 
mg/mL (Table 3.2). All extracts had an increasing ICA with increasing concentrations, and 
the hexane extract had the highest ICA (81.3 %) at the highest concentration tested (10 
mg/mL; Table 3.2).  
 
 Table 3.2. Iron and copper chelating activity of extracts of C. edulis.  
 ICA CCA 
Extract / Compound 1 mg/mL 5 mg/mL 10 mg/mL 1 mg/mL 5 mg/mL 10 mg/mL 
Hexane 45.7 ± 2.0g 72.7 ± 0.9cd 81.3 ± 1.8b n.a n.a n.a 
Dichloromethane 50.8 ± 2.2ef 68.6 ± 1.5d 76.3 ± 1.3c 3.4 ± 2.2gh 8.1 ± 1.5f 7.1 ± 1.5f 
Chloroform 31.4 ± 1.7h 46.3 ± 1.6fg 51.6 ± 1.4e n.a n.a 0.5 ± 0.8h 
Ethyl Acetate n.a n.a n.a 3.1 ± 0.8gh 12.9 ± 0.9e 25.9 ± 1.1d 
Methanol 12.7 ± 1.9i 32.7 ± 0.8h 45.3 ± 1.3g 5.81 ± 2.1fg 30.8 ± 1.5c 48.3 ± 0.7b 
EDTA* 89.7 ± 0.4a 89.2 ± 0.5a 
Each value represents mean ± SEM (n = 12); *positive control at concentration at 1 mg/mL. 
Significant differences between concentrations, extracts and positive control were 
determined by the Duncan HSD test (p < 0.05) and are indicated by different letters (a-h). 
n.a: no activity. 
 
Regarding the CCA, only the ethyl acetate and methanol extracts had an activity 
dependent of the extract concentration, and the highest result was obtained with the 
methanol extract at the concentration of 10mg/mL (48.3%, Table 2). None extract showed a 
higher activity than the obtained with positive control (EDTA). 
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3.1.3 Iron reducing power 
 In this assay, the Fe3+ to Fe2+ reduction power of the extracts was tested at 1, 5 and 
10 mg/ml, and results are depicted on Fig. 3.2. 
Figure 3.2: Iron reducing activity of extracts of C.edulis. Solid bars and error bars 
represent the average and standard errors values respectively (n = 12). Results are 
calculated in respect to the BHT, used as a positive control. Significant differences between 
concentrations and extracts were determined by the Duncan HSD test (p < 0.05) and are 
indicated by different letters (a-i).  
 
The hexane, dichloromethane, chloroform and ethyl acetate extracts showed an 
increasing reducing power activity with increasing concentrations, and the highest result 
was obtained with the ethyl acetate extract at the concentration of 10mg/mL (76.6 %). 
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3.1.4. Nitric oxide (NO)-scavenging activity 
 The NO scavenging capacity of the extracts was determined at the concentrations of 
1, 5 and 10 mg/mL, and results are summarized on Fig. 3.3.  
Figure 3.3. NO scavenging activity of extracts of C.edulis. Each value represents mean ± 
SEM (n = 12). Significant differences between extracts and concentrations were determined 
by the Duncan HSD test (p < 0.05) and are indicated by different letters (a-b). Ascorbic acid 
was used as a positive control at the concentration of 1 mg/mL.  
 
Only the methanol extract had a dose-response effect, with an increase in the % of 
NO-scavenging activity with increasing concentrations of the extract, and the highest 
activities were obtained with the concentrations of 5 and 10 mg/mL, (40.1% and 41.5%, 
respectively. The hexane and the dichloromethane extracts had a decreasing NO scavenging 
activity from the concentrations of 1 and 5 mg/mL to the highest concentration tested 
(10mg/mL), while ethyl acetate had a decrease from the concentration 5 to 10mg/mL. 
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3.2. Total phenolics (TPC), flavonoids (TFC) and condensed tannins content (TCTC) 
 The methanol extracts had the highest TPC (378.8 mg GAE/g, DW), followed by 
the ethyl acetate (260.5 mg GAE/g, DW) and chloroform (219.6 mg GAE/g, DW; Table 
3.3).  
 
Table 3.3. Total phenolics (TPC, mg GAE/g DW), flavonoids (TFC, mg RE/g DW) and 
condensed tannins contents (TCTC, mg CE/g DW) of C. edulis extracts.  
Extract TPC (mg GAE/g, DW) TFC (mg RE/g, DW) TCTC (mg CE/g, DW) 
Hexane 196 ± 3c 299 ± 5d 95.4 ± 6.4a 
Dichloromethane 200 ± 7c 369 ± 8b 102 ± 10a 
Chloroform 219 ± 4bc 319 ± 5c 94.6 ± 6a 
Ethyl acetate 260 ± 4b 383 ± 6b 100 ± 5a 
Methanol 378 ± 4a 587 ± 6a 58.0 ± 2.7b 
 
Results are expressed as mean ± SEM (n = 12) and are calculated in respect to the negative 
control. Significant differences between extracts were determined by the Duncan HSD test 
(p < 0.05) and are indicated by different letters (a-d). 
 
 The methanol extracts had the highest level of flavonoids (587 mg RE/g, DW), 
followed by the ethyl acetate (383 mg RE/g, DW), dichloromethane extracts (369 mg RE/g, 
DW), chloroform (318 mg RE/g, DW) and hexane extracts (298 mg RE/g, DW; Table 3.3). 
Regarding tannins, the highest amounts were observed in the dichloromethane (102 mg CE/ 
g, DW), ethyl acetate (100 mg CE/ g, DW), hexane (95.3 mg CE/ g, DW) and chloroform 
extracts (94.6 mg CE/ g, DW), which are statistically similar, followed by the methanol 
extract (58 mg CE/ g, DW) (Table 3.3). 
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3.3. Enzyme inhibition assays 
3.3.1. Cholinesterase inhibition 
 The extracts were tested for inhibition of enzymes related with neurodegenerative 
diseases, namely AChE, BChE and TYRO, and results are depicted on Tables 3.4 (AChE), 
3.5 (BChE) and 3.6 (TYRO). The inhibitory activity (%) was classified as potent (>50%), 
moderate (30-50%), low (<30%) and nil (<5%) (Vinutha et al, 2007). 
 According to this classification the ethyl acetate and the methanol extracts had 
potent AChE inhibition, even at the lowest concentration tested (1 mg/mL), and the highest 
results were obtained with the methanol extract, with inhibition values of 75.1% (1 
mg/mL), 87.2% (5 mg/mL) and 86.2% (10 mg/mL). Dichloromethane also had potent 
AChE inhibition at 10 mg/mL (62.9%), while the remaining extracts had moderate activity 
at the highest concentration tested. There is no significant difference in inhibition of AChE 
activity among the methanol extract and positive control galantamine (p<0.05). 
 
 
Table 3.4. AChE inhibitory activity of extracts of C. edulis.  
Extract 1 mg/mL 5 mg/mL 10 mg/mL Galanthamine 
Hexane n.a 14.4 ± 4.6g 37.0 ± 5.2def 
89.9 ± 0.7a 
Dichloromethane 21.4 ± 3.2fg 31.4 ± 3.5ef 62.9 ± 7.5bc 
Chloroform 44.4 ± 2.3de 49.4 ± 7.9cd 36.8 ± 7.0def 
Ethyl acetate 50.4 ± 7.7cd 80.8 ± 2.8a 75.6 ± 1.9ab 
Methanol 75.1 ± 0.7ab 87.2 ± 1.1a 86.2 ± 0.7a 
 
Each value represents mean ± SEM of at least 6 replicates. Significant differences between 
concentrations of the same extract were determined by the Duncan HSD test (p < 0.05) and 
are indicated by different letters (a-g). Galanthamine was used as a positive control, at 1 
mg/mL. n.a: no activity. 
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 The hexane extract had a potent BChE inhibition at all tested concentrations. The 
chloroform extract showed a potent BChE inhibition at 1 and 5 mg/mL, and a moderate 
BChE inhibition at the highest concentration tested (10 mg/mL). The dichloromethane, 
ethyl acetate and methanol extracts at the lowest concentration tested (1 mg/mL) show a 
potent BChE inhibition, and the remaining extracts and concentration has a moderate BChE 
inhibition, except for the ethyl acetate at concentration at 10 mg/mL, which had a low 
BChE activity. 
 
Table 3.5. BChE inhibitory activity of extracts of C. edulis. 
Extract 1 mg/mL 5 mg/mL 10 mg/mL Galanthamine 
Hexane 59.4 ± 1.04b 57.8 ± 1.21bc 58.6 ± 3.29b 
81.3 ± 1.3a 
 
Dichloromethane 56.4 ± 1.21bc 43.6 ± 1.69de 35.6 ± 1.85f 
Chloroform 58.7 ± 1.09b 55.4 ± 1.93bc 40.2 ± 3.05ef 
Ethyl acetate 60.4 ± 0.86b 39.2 ± 2.96ef 21.2 ± 0.81g 
Methanol 52.1 ± 1.2c 46.2 ± 2.11d 40.5 ± 1.08ef 
 
Each value represents mean ± SEM of at least 6 replicates. Significant differences between 
concentrations of the same extract were determined by the Duncan HSD test (p < 0.05) and 
are indicated by different letters (a-g). Galanthamine was used as a positive control, at 1 
mg/mL. 
 
 
3.3.2. Tyrosinase inhibition 
 The methanol extract had a moderate TYRO inhibition at all concentrations tested 
while the ethyl acetate extract have the lowest TYRO inhibition, at all concentrations. The 
dichloromethane extract had a moderate TYRO inhibition at concentration at 5 mg/mL 
(32.0% ± 1.2) and at 10 mg/mL (36.5% ± 2.5).  
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Table 3.6. Tyrosinase inhibitory activity of extracts of C.edulis.  
Extract 1 mg/mL 5 mg/mL 10 mg/mL Arbutin 
Hexane 6.5 ± 1.1gh 14.9 ± 1.0f 36.9 ± 0.6c 
78.2 ± 2.1a 
Dichloromethane 25.8 ± 1.1e 32.0 ± 1.2d 36.5 ± 2.5cd 
Chloroform n.d n.d n.d 
Ethyl acetate 9.3 ± 0.5g 6.9 ± 0.7g 2.2 ± 1.6h 
Methanol 43.1 ± 1.7b 33.4 ± 0.8cd 42.6 ± 0.9b 
 
Each value represents mean ± SEM (n = 12). Significant differences between 
concentrations of the same extract were determined by the Duncan HSD test (p < 0.05) and 
are indicated by different letters (a-h). Arbutin was used as positive control, at the 
concentration of 1 mg/mL. (n.d – not dertemined). 
 
3.4. Neuroprotective activity using cell-based method 
3.4.1. Protective effect against H2O2-induced injury in neuronal cells 
 In this work the protective effect of C.edulis extracts against cell injury caused by 
H2O2 treatment was evaluated on the human neuroblastoma SH-SY5Y cell line. In order to 
find the non-toxic concentrations samples were first applied at different concentrations 
(3.125, 6.25, 12.5, 25, 50 and 100 μg/mL) on SH-SY5Y cells, and viability was determined 
by the MTT method. Results were compared with control cells treated with DMSO at the 
maximum concentration used in the wells (0.5%, (v/v)). 
 All the extracts significantly increased the viability of SH-SY5Y cells, especially 
the methanol extract at the concentration of 100 μg/mL (287.7% of cell viability; Fig. 3.4), 
and thus, all samples were used to determine the protective effect against H2O2 – induced 
injury.  
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Figure 3.4. Cytotoxic effect of extracts of C.edulis in a human neuroblastoma cell line (SH-
SY5Y cells). Solid bars and errors bars represent the average and standart error values, 
respectively (n = 6). *** Indicate a significan increase of cell viability of treated cells 
compared to control cells containing DMSO (0.5%, v/v; p < 0.001.  
 
 
 In order to select the H2O2 concentration required to reduce cell viability by 50% 
cells were treated with different concentrations of H2O2 (0.25 – 1 mM) for different periods 
of incubation (15-60 min.) and cell viability was evaluated by the MTT assay. As can be 
seen on Fig. 3.5 the treatment of SH-SY5Y with 1 mM of H2O2 for 30 min. resulted in a 
reduction of cell viability to 48.9%. Thus, these conditions were selected and used in the 
following assays. 
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Figure 3.5. Cytotoxic effect of different concentrations of H2O2 applied for different time 
period on SH-SY5Y cells. Solid bars and error bars represent the average and standard error 
values, respectively (n = 6). The horizontal dashed line represents 50% of cell viability. 
Significant differences between extracts were determined by the Duncan HSD test (p < 
0.05) and are indicated by different letters (a-h). 
  
 In order to determine the neuroprotective potential of C. edulis, hexane, 
dichloromethane, ethyl acetate and methanol extracts were applied to SH-SY5Y cells at 
concentrations ranging from 3.125 to 100 μg/mL for 24h.After extract removal, cells were 
challenged with H2O2 (1 mM for 15 min), and dissolved in culture medium containing 
DMSO at the highest concentration used (0.5% v/v). Cell viability was measured by the 
MTT method. As can be seen on Fig. 3.6 the pre-treatment of the cells with the extracts 
before exposure to H2O2 resulted in an increase in cell viability, except for the ethyl acetate 
extract at the concentration of 25 μg/mL. The dichloromethane and methanol extracts had 
the highest capacity to protect cells from H2O2 injury, with values of cell viability of 
105.1% and 143.4%, respectively, at the concentration of 50 μg/mL.   
Results 
44 
 
 
Figure 3.6. Protective effect of the C. edulis extracts in SH-SY5Y cells pre-treated with the 
extracts at the concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL for 24h, and 
exposed to 1mM H2O2 for 15 min. Solid bars and error bars represent the average  and 
standard error values, respectively (n = 6). *** Indicate a significan increase of cell 
viability of treated cells compared to control cells containing DMSO (0.5%, v/v; p < 0.001. 
 
3.4.2. Anti-inflammatory activity on LPS-stimulated microglia cells 
 In order to evaluate the anti-inflammatory activity of the C. edulis extracts on LPS-
stimulated microglia cells, the cytotoxic effect of different concentrations of the extracts 
(3.125, 6.25, 12.5, 25, 50 and 100 μg/mL) was first determined for 24h on N9 cells. Cell 
viability was determined by the MTT method and results were compared with control cells 
treated with DMSO (0.5%, v/v).  
 An increase in cell viability was observed after application of all samples (Fig. 3.7). 
Thus, and having in mind the results obtained in the previous assays, the methanol extract 
was selected to be tested for anti-inflammatory activity.  
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Figure 3.7. Cytotoxic effect of extracts of C. edulis in murine microglia cells (N9 cell line). 
Solid bars and errors bars represent the average and standard error values, respectively (n 
=6). *** Indicate a significan increase of cell viability of treated cells compared to control 
cells containing DMSO (0.5%, v/v; p < 0.001). 
 
 For the evaluation of the anti-inflammatory activity, the N9 cells were stimulated 
with 200 μL of LPS during 24h in the presence or absence of methanol extract, and the 
level of nitrites in the culture medium was measured by the Griess method. The incubation 
of N9 cells for 24h in the presence of LPS (10 μg/mL) induced the production of nitrites. 
 The methanol extract was selected for this assay because it was, in a general way, 
the extract whit the better results and it is a viable candidate for future works.  
 
 The application of the methanol extract at the concentration of 100 μg/mL 
significantly reduced NO production (1.53 μM), when compared with control cells (6.66 
μM), corresponding to a 77% of decrease in NO production (Fig. 3.8).  
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Figure 3.8. NO production in N9 cell line. Cells were treated with 10 μg/mL of LPS alone, 
or in combination with selected extract concentration. After 24h of incubation the NO 
concentration was determined using the Griess reagent. Solid bars and errors bars represent 
the average and standard error values, respectively (n=5). Results were expressed as μM of 
NO production. 
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4. Discussion 
 
4.1. Antioxidant activities  
 In this work it was performed a screening of the RSA on the DPPH radical of 
methanol extracts leaves of 26 halophytes, and it was identified at least 5 species with a 
high antioxidant activity, namely C. edulis (95.7%), F. laevis (95.2%), L. algarvense 
(95.7%), P. maritimum (94.5%) and T. africana (95.0%), all higher than the positive 
control (89.1%).  
The species C. edulis was selected for further studies due to its high RSA, and 
also because it is an invasive plant and very abundant in our region. The high RSA of 
C.edulis are in agreement with previous studies showing that it has a strong antioxidant 
activity, possible due to is high phenolic content (Falleh et al., 2011; Custódio et al., 
2012; Ibtissem et al., 2012; Omoruyi et al., 2012; Rodrigues et al., 2014). It is 
important to note that the sample analysed is a crude extract, composed by a mixture of 
several compounds, while BHT is a pure compound. Moreover, some studies showed 
that BHT, and other synthetic antioxidants, can be toxic and have a carcinogenic 
activity, and so the importance in search for new natural antioxidants (Williams et al., 
1999; Suhaj, 2006; Custódio et al., 2012; Okoko et al., 2012). Compounds with high 
antioxidant activity have an important role in the protection of cells against injuries 
caused by oxidative stress (Finkel et al., 2000). Since neurodegenerative diseases are 
potentiated by ROS, it is crucial avoid their formation and accumulation. There is some 
indications that the intake of this antioxidants can prevent ageing and oxidative stress, 
leading to a decreased of the risks of stress-related diseases (Vina et al., 2004; Dai et al., 
2010; Falleh et al., 2011; Custódio et al., 2012).  
As showed before, the high levels of metals, like iron and copper, can influence 
the production of free radicals, and consequently the increase of ROS. Through the iron 
and copper chelating activity and iron reducing power, we can evaluated the capacity of 
the extracts to capture or reduced this metals and avoid the increasing of oxidative 
stress.  
In this study, the hexane and dichloromethane extracts of C. edulis had a high 
capacity to chelate iron. This species had previously showed a high ICA, which is 
correlated with the phenolic content (Omoruyi et al., 2012). For copper, the methanol 
extract had a high activity at 10 mg/mL. 
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 According the results for the iron reducing power, the ethyl acetate extract was 
the most effective with 76.6% of activity at a concentration at 10 mg/mL, followed by 
dichloromethane and chloroform extracts at same concentration. In other studies the 
methanol extract at lowest concentration tested showed a high iron reducing activity, 
which was not observed in this study (Custódio et al., 2012). This result can be 
explained by the differences between the extractions methods realised.  
The protection against iron-induced free radical reactions can be associated with 
antioxidant properties of flavonoids (Cao et al., 1997). 
The NO plays an important role in modulation of blood flow, neurotransmission 
and on the immune system (Moncada et al., 2006; Pacher et al., 2007). At high 
concentrations it can be toxic to the cells, and can react with O2
- producing peroxynitrite 
(PN) which is an extremely active oxidant agent (Taylor et al., 2013). In the search of 
antioxidant compounds, it was performed the NO-scavenging assay, which showed that 
methanol extract had the highest NO scavenging activity at the highest concentration 
tested (10 mg/mL). Another study, with other extracts tested showed that C. edulis had a 
high NO scavenging activity (Omoruyi et al., 2011). Banerjee et al reported that polar 
solvents, like ethanol and methanol always show the high activity, probably because of 
their high phenolic contents (Martins et al., 2011).  
 
4.2 Phytochemical analysis 
 Phenolics compounds have multiple biological properties, including antioxidant 
activity (Kahkonen et al., 1999; Falleh et al., 211). Previous studies indicates the 
presence of phenolic, flavonoids and tannins compounds in C. edulis (Hanen et al., 
2009; Falleh et al., 211; Custódio et al., 2012; Omoruyi et al., 2012), and probably is 
the main cause of the several properties assigned to this species, like antimicrobial, anti-
infective and antifungal (Falleh et al., 2011; 2013). The methanol extract had a strong 
antioxidant activity and this one can be related to a high content of phenolic compounds 
(Falleh et al., 2013). Previous report identify several compounds in this species, such as 
rutin, neohesperidin, hyperoside, cactichin and ferulic acid (Custódio et al., 2012). In 
this work the extracts revealed a high content of total phenolics, flavonoids and 
condensed tannin compounds which can explain the high antioxidant activity. The 
methanol extract had a high value of total flavonoid content (587.05 mg RE/g DW), 
which has been reported to display anti-tumoral, anti-inflammatory activity and 
inhibition of several enzymes, such as lipoxygenase, cyclooxygenase, monooxygenase, 
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xanthine oxidase, mitochondrial succinoxidase and NADH-oxidase, phospholipase A2, 
and protein kinases (Cao et al., 1997). 
 
4.3. Enzyme inhibition assays 
4.3.1. Cholinesterase inhibition 
 The actual drugs administrated in AD patients, like tacrine, donepezil and the 
natural products rivastigmine and galanthamine, have the function to block the action of 
both cholinesterases, AChE and BChE, increasing the levels of this neurotransmitter 
(Zarotsky et al 2003; Natarajan et al., 2009). Some of this drugs have adverse side-
effects and are toxic, so it is important the search for natural solutions which reduce the 
toxicity and the side-effects, or at least reduced at a minimum level ((Hansen et al., 
2008; Natarajan et al., 2009)). The AChE and BChE inhibitory activities were classified 
as potent (> 50% inhibition), moderate (30-50% inhibition), low (<30% inhibition) or 
nil (< 5% inhibition) (Vinutha et al., 2007). According to this classification the ethyl 
acetate and the methanol extracts had potent AChE inhibitory activity. In a general way 
all extracts tested have a potent or moderate BChE inhibitory activity, depending on the 
concentration tested. This extracts might be a source for compounds with the capacity to 
increase cholinergic activity through the inhibition of AChE and BChE. Some studies 
show that inhibition of ChE by this compounds not only rise the ACh levels, but also 
avoid the development of Aβ plaques, since ChEIs can activate α-secretase, which acts 
on the Aβ precursor and lead to Aβ plaques formation (Mesulam et al., 2002; Natarajan 
et al., 2009; Custódio et al., 2012). This compounds can have an important role in the 
prevention of neuronal death caused by AD (Giacobini 2004; Custódio et al., 2012). The 
ChE inhibitory activity of C. edulis show that it can be a source of compounds with 
therapeutic uses in ND, like AD and PD (Williams et al., 2011; Custódio et al., 2012). 
In another study, it has been shown that flavonoids can inhibit some enzymes, such as 
monooxygenase, by reacting with free radicals generated at the enzyme's active site 
(Cao et al, 1997). 
 
4.3.2. Tyrosinase inhibition  
 The inhibitory activity of tyrosinase is important in disorders, like 
hyperpigmentary diseases and post-inflammatory hyperpigmentation (Kolbe et al., 
2012). The tyrosinase also contribute to neuromelanin formation, which is found in 
nigral dopaminergic cells (Hasewaga 2010). Previous studies showed that the 
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expression of this enzyme increases the neuronal susceptibility to oxidizing conditions 
(Tessari et al., 2013). In this work methanol extract had moderate TYRO activity, while 
the other extracts had, generally, low activity. In 2004, Kang et al identify the Ecklonia 
stolonifera, a brown algae, as had tyrosinase inhibitory activity. They show that active 
ethyl acetate fraction of the methanol extract of E. stolonifera exhibit a high tyrosinase 
inhibitory activity, higher than the arbutin used as positive control. The phloroglucinol 
(phenol derivate), eckstolonol (phlorotannin), eckol (phlorotannin), phlorofucofuroeckol 
A (phlorotannin), and dieckol (phlorotannin) compounds were identify as the 
responsible for the tyrosinase inhibitory activity in this algae (Kang et al, 2004). Other 
compound, oxyresveratrol, show to have a dose-dependent and potent inhibitory effect 
on tyrosinase activity (Kim et al, 2002).  
 
4.4 Neuroprotective activity 
 Oxidative stress is the major factor implicated in neurodegenerative diseases 
(like AD and PD). Previous studies showed that ROS induces cell dead and the H2O2 
can cause injuries in several cell types (Gao et al., 2001; Kwon et al., 2011). It was also 
demonstrated that the effect of ROS can be blocked by the addiction of antioxidants 
(Kwon et al., 2011). In this work it was assed the capacity of the extracts to protect in 
vitro neuronal cells against oxidative stress induced by H2O2. The methanol extract 
protected the cells against the injury. Possibly we can related this good results with the 
high value of antioxidant activity and the higher concentration of phenolic compounds 
of this extract, particularly the flavonoids content. Other studies have been done on the 
protective effect of flavonoids on neurons, and showed that high levels in scavenging 
free-radicals could protect neuronal cells from oxidative stress (Gao et al., 2001) We 
have not found any previous work for this assay on this species, but comparing with 
another plants (Custodio et al., 2013) the C. edulis showed to have better protective 
effect than the results for the cork aok and holm oak, for example. Gao et al, in 2001, 
showed that the root of Scutellaria baicalensis Georgi, a traditional Chinese herb 
medicine and used as an anti-inflammatory drug, had a high flavonoid content and 
showed a high scavenge hydroxyl radicals, DPPH radicals and enzymatic or non-
enzymatic inhibition induced by mitochondria lipid peroxidation.  
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4.5. Anti-inflammatory activity on LPS-stimulated microglia cells 
 The methanol extract of C. edulis reduced the NO production in vitro by 
microglia cells by 77%, when compared to LPS-stimulated cells, thus suggesting that 
this extracts has compounds with anti-inflammatory properties. Microglial cells can 
remove infectious agents, release trophic factors, remove damaged cells and produce 
cytokines, which make the communication among neuronal and other glial cells 
(Bodrato et al., 2009). Despite its capacity to tissue repair and neuroprotection, when 
this cells are constantly activated, lead to a chronic inflammation, producing 
neurotoxins, like pro-inflammatory cytokines and NO, contributing for the pathogenesis 
of neurodegenerative diseases (Emerit et al., 2004; Bodrato et al., 2009). It becomes 
increasingly important to find substances that had anti-inflammatory activity for 
potential treatment for these diseases (Falleh et al., 2011). Other study shows that 
Salicornia bigelovii, another halophyte, suppress the increasing production of NO on 
LPS-stimulated BV-2 microglial cells (Kang et al, 2013). This study suggests that S. 
bigelovii can be an effective anti-inflammatory agent (Kang et al, 2013). They 
connected this activity with high antioxidant activity of this species. S. bigelovii have 
active compounds such as triterpenoids, flavones, glycosides, saponins, vitamins and 
minerals (Kang et al, 2013). Another study shows that flavonoids have an anti-
inflammatory activity, which may explain the high activity of methanol extract, along 
with high flavonoid content of this extract (Talhouk et al, 2007).  
 
 
5. Conclusion and future work 
 This study shows the potential of halophytes as sources of antioxidant 
compounds in particular the Carpobrotus edulis species. This species had a high 
antioxidant activity, was rich in phenolic compounds, display a high capacity to inhibit 
AChE and BChE enzymes and a good neuroprotective and anti-inflammatory activity 
using neuronal and microglia cells as in vitro models. 
 Future studies should be performed, in order to identify and isolate the bioactive 
compounds present in the methanol extract, and determine its mode of action. 
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